Lactobacillus reuteri AN417 cell-free culture supernatant as a novel antibacterial agent targeting oral pathogenic bacteria
- PMID: 33452304
- PMCID: PMC7810884
- DOI: 10.1038/s41598-020-80921-x
Lactobacillus reuteri AN417 cell-free culture supernatant as a novel antibacterial agent targeting oral pathogenic bacteria
Abstract
Lactobacillus reuteri AN417 is a newly characterized probiotic strain. The activity of AN417 against oral pathogenic bacteria is unknown. We investigated the antibacterial activity of cell-free L. reuteri AN417 culture supernatant (LRS) against three oral pathogens: Porphyromonas gingivalis, Fusobacterium nucleatum, and Streptococcus mutans. P. gingivalis and F. nucleatum have been implicated in periodontal disease, whereas S. mutans causes dental caries. Exposing these oral pathogenic bacteria to LRS significantly reduced their growth rates, intracellular ATP levels, cell viability, and time-to-kill. The minimal inhibitory volume of LRS was 10% (v/v) against P. gingivalis, 20% (v/v) for F. nucleatum, and 30% (v/v) for S. mutans. LRS significantly reduced the integrity of biofilms and significantly suppressed the expression of various genes involved in P. gingivalis biofilm formation. The L. reuteri AN417 genome lacked genes encoding reuterin, reuteran, and reutericyclin, which are major antibacterial compounds produced in L. reuteri strains. LRS treated with lipase and α-amylase displayed decreased antibacterial activity against oral pathogens. These data suggest that the antibacterial substances in LRS are carbohydrates and/or fatty acid metabolites. Our results demonstrate that LRS has antimicrobial activity against dental pathogenic bacteria, highlighting its potential utility for the prevention and treatment of P. gingivalis periodontal disease.
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Inhibitory effect of Lactobacillus reuteri on periodontopathic and cariogenic bacteria.J Microbiol. 2011 Apr;49(2):193-9. doi: 10.1007/s12275-011-0252-9. Epub 2011 May 3. J Microbiol. 2011. PMID: 21538238
-
Antibacterial and antibiofilm activities of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) against periodontopathic bacteria.Microb Pathog. 2016 Oct;99:196-203. doi: 10.1016/j.micpath.2016.08.025. Epub 2016 Aug 24. Microb Pathog. 2016. PMID: 27565090
-
Antimicrobial activity of red wine and oenological extracts against periodontal pathogens in a validated oral biofilm model.BMC Complement Altern Med. 2019 Jun 21;19(1):145. doi: 10.1186/s12906-019-2533-5. BMC Complement Altern Med. 2019. PMID: 31226983 Free PMC article.
-
An insight into the last 5-year patents on Porphyromonas gingivalis and Streptococcus mutans, the pivotal pathogens in the oral cavity.Expert Opin Ther Pat. 2024 Jun;34(6):433-463. doi: 10.1080/13543776.2024.2349739. Epub 2024 May 20. Expert Opin Ther Pat. 2024. PMID: 38684444 Review.
-
Flavonoids effects against bacteria associated to periodontal disease and dental caries: a scoping review.Biofouling. 2024 Feb;40(2):99-113. doi: 10.1080/08927014.2024.2321965. Epub 2024 Feb 29. Biofouling. 2024. PMID: 38425046 Review.
Cited by
-
Isolation, Identification and Antibacterial Characteristics of Lacticaseibacillus rhamnosus YT.Foods. 2024 Aug 27;13(17):2706. doi: 10.3390/foods13172706. Foods. 2024. PMID: 39272473 Free PMC article.
-
Vibriocidal efficacy of Bifidobacterium bifidum and Lactobacillus acidophilus cell-free supernatants encapsulated in chitosan nanoparticles against multi-drug resistant Vibrio cholerae O1 El Tor.BMC Infect Dis. 2024 Sep 2;24(1):905. doi: 10.1186/s12879-024-09810-2. BMC Infect Dis. 2024. PMID: 39223499 Free PMC article.
-
A bacteriocin expression platform for targeting pathogenic bacterial species.Nat Commun. 2024 Jul 27;15(1):6332. doi: 10.1038/s41467-024-50591-8. Nat Commun. 2024. PMID: 39068147 Free PMC article.
-
Bioactive Hydrogel Formulation Based on Ferulic Acid-Grafted Nano-Chitosan and Bacterial Nanocellulose Enriched with Selenium Nanoparticles from Kombucha Fermentation.J Funct Biomater. 2024 Jul 22;15(7):202. doi: 10.3390/jfb15070202. J Funct Biomater. 2024. PMID: 39057323 Free PMC article.
-
Limosilactobacillus reuteri in immunomodulation: molecular mechanisms and potential applications.Front Immunol. 2023 Aug 9;14:1228754. doi: 10.3389/fimmu.2023.1228754. eCollection 2023. Front Immunol. 2023. PMID: 37638038 Free PMC article. Review.
References
-
- Seguier S, Gogly B, Bodineau A, Godeau G, Brousse N. Is collagen breakdown during periodontitis linked to inflammatory cells and expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gingival tissue? J. Periodontol. 2001;72:1398–1406. doi: 10.1902/jop.2001.72.10.1398. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical